BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

Merck and Mycenax Biotech Forge Partnership for Bioprocessing Innovation

Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...

January 24, 2024 | News

Thermo Fisher's RNA Facility in Monza, Italy, Gains GMP Approval from Italian Medicines Agency (AIFA)

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (A...

January 19, 2024 | News

Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 09, 2024 | News

Thermo Fisher Introduces PangenomiX Array for Large-Scale Disease and Pharmacogenomics Research

Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more ...

January 05, 2024 | News

Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC

In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...

December 18, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

December 13, 2023 | News

Plenary Session on Biotech Ecosystem: Views from Key Opinion Leaders Highlights at #GlobalBioIndia2023: A Glimpse into the Future of Biotech Innovation

This pivotal evolution was underscored by Rajesh Gokhale, Secretary, Department of Biotechnology, and Chairman of the Biotechnology Industry Research Assis...

December 05, 2023 | News

Insilico Medicine Launches First Human Study for ISM5411, Oral PHD Inhibitor for IBD

ISM5411 is an oral, PHD-specific inhibitor that facilitates the treatment of IBD by inducing the expression of gut barrier protective genes. ISM5411 is ...

December 05, 2023 | News

Is Asia ready to be the next global biotech hub?

As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...

November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

November 15, 2023 | News

NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

NSF, a leading global public health and safety organization, is pleased to announce that Novozymes, a leader in biosolutions, has become the world&rs...

November 10, 2023 | News

Thirty-One mRNA Leaders Launch First Global Organization Dedicated to Advancing mRNA Medicines

31 biotechnology, biopharma and life science companies and educational institutions at the forefront of mRNA and next-generation encoding RNA therapeutics ...

November 02, 2023 | News

Waters Launches OligoWorks™ SPE Workflow and Kits for Faster Oligonucleotide Bioanalysis

Delivers up to 2x[i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support robust quantitati...

October 23, 2023 | News

Thermo Fisher & Boehringer Ingelheim Join Forces for NSCLC Companion Diagnostics in Japan and the US

To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...

October 20, 2023 | News

Stay Connected